ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 868,34
0,17%
Dow Jones
44 421,91
-0,28%
DAX
21 424,41
0,09%
Brent Oil
74,975
-0,51%
Bitcoin
99 498,71
-1,89%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. AbSci Corporation (ABSI) Cours

AbSci Corporation

AbSci Corporation (ABSI)

NASDAQ
3,70
-0,01
(-0,27%)
Fermé 04 Février 10:00PM
Retardé de 15 minutes
3,73
0,03
( 0,81% )
Avant marché: 11:51AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
3,73
Prix Achat
3,72
Prix Vente
3,75
Volume échangé
8 423
0,00 Fourchette du Jour 0,00
2,45 Plage de 52 semaines 6,72
Cap du marché
428,412M
Clôture Veille
3,70
Ouverture
-
Dernière Transaction
446
@
3.73
(formt)
Dernière heure de transaction
11:51:17
Volume financier
-
VWAP
-
Volume moyen (3 m)
4 030 167
Actions en circulation
114 855 759
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,84
Bénéfice par action (BPA)
-0,96
Chiffre d'affairess
5,72M
Bénéfice net
-110,57M

À propos de AbSci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Secteur
Coml Physical, Biologcl Resh
Industrie
Coml Physical, Biologcl Resh
Site Web
www.absci.com
Siège social
Wilmington, Delaware, USA
Fondé
-
AbSci Corporation est coté dans le secteur Coml Physical, Biologcl Resh de la NASDAQ avec le ticker ABSI. Le dernier cours de clôture d'AbSci était de US$3,70. Au cours de la dernière année, les actions de AbSci ont été négociées dans une fourchette de prix de US$ 2,45 à US$ 6,72.

AbSci compte actuellement 114 855 759 actions en circulation. La capitalisation boursière d'AbSci est de US$424,97 million. AbSci a un ratio cours/bénéfice (ratio PE) de -3.84.

ABSI Dernières nouvelles

Plus de nouvelles

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

VANCOUVER, Wash. and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be...

22 Janvier 2025
GlobeNewswire Inc.

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 PR Newswire VANCOUVER, BC, Jan. 17, 2025 USA News Group News Commentary  Issued on behalf of Avant Technologies...

17 Janvier 2025
PR Newswire (US)

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 PR Newswire VANCOUVER, BC, Jan. 17, 2025 USA News Group News Commentary  Issued on behalf of Avant Technologies...

17 Janvier 2025
PR Newswire (US)

Form 8-K - Current report

15 Janvier 2025
Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

11 Janvier 2025
Edgar (US Regulatory)

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

VANCOUVER, Wash. and PARIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to...

10 Janvier 2025
GlobeNewswire Inc.

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

VANCOUVER, Wash., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to...

08 Janvier 2025
GlobeNewswire Inc.

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

VANCOUVER, Wash. and BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Invetx, a pioneer in protein-based...

06 Janvier 2025
GlobeNewswire Inc.

Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

VANCOUVER, Wash. and NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be...

02 Janvier 2025
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.16-4.113110539853.894.043.531215673.76229143CS
40.38511.5097159943.3454.42.654580183913.38293305CS
12-0.37-9.02439024394.14.562.4540301673.32647299CS
260.277.803468208093.464.62.4522641233.47996069CS
52-0.58-13.45707656614.316.722.4518848963.86421593CS
156-3.22-46.33093525186.959.681.111110174613.73677489CS
260-17.27-82.23809523812131.53011.11119739984.45969518CS

ABSI - Frequently Asked Questions (FAQ)

What is the current AbSci share price?
The current share price of AbSci is US$ 3,73
How many AbSci shares are in issue?
AbSci has 114 855 759 shares in issue
What is the market cap of AbSci?
The market capitalisation of AbSci is USD 424,97M
What is the 1 year trading range for AbSci share price?
AbSci has traded in the range of US$ 2,45 to US$ 6,72 during the past year
What is the PE ratio of AbSci?
The price to earnings ratio of AbSci is -3,84
What is the cash to sales ratio of AbSci?
The cash to sales ratio of AbSci is 74,3
What is the reporting currency for AbSci?
AbSci reports financial results in USD
What is the latest annual turnover for AbSci?
The latest annual turnover of AbSci is USD 5,72M
What is the latest annual profit for AbSci?
The latest annual profit of AbSci is USD -110,57M
What is the registered address of AbSci?
The registered address for AbSci is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the AbSci website address?
The website address for AbSci is www.absci.com
Which industry sector does AbSci operate in?
AbSci operates in the COML PHYSICAL, BIOLOGCL RESH sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
EVAXEvaxion Biotech AS
US$ 4,14
(72,50%)
13,79M
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 209,89
(35,14%)
79,36k
PLTUDirexion DAily PLTR Bull 2X Shares
US$ 44,58
(35,13%)
112,71k
IVVDInvivyd Inc
US$ 1,32
(24,53%)
11,82M
SUGPSU Group Holdings Ltd
US$ 1,20
(21,24%)
1
UOKAMDJM Ltd
US$ 0,1686
(-29,16%)
1,01M
UPCUniverse Pharmaceuticals Inc
US$ 0,3056
(-26,78%)
107,99k
TENXTenax Therapeutics Inc
US$ 4,48
(-24,71%)
98
EJHE Home Household Service Holdings Ltd
US$ 0,78
(-23,53%)
41,38k
MYSZMy Size Inc
US$ 1,67
(-21,23%)
276
EVAXEvaxion Biotech AS
US$ 4,14
(72,50%)
13,79M
IVVDInvivyd Inc
US$ 1,32
(24,53%)
11,82M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1619
(-16,93%)
3,48M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0401
(-13,20%)
3,26M
PLTRPalantir Technologies Inc
US$ 99,20
(18,46%)
2,58M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ABSI
AbSci
USOTC
ITOCY
Itochu (PK)
TG
CVJ
Cann
TG
0VU0
Lufax
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces